×
About 273 results

ALLMedicine™ Alopecia Totalis Center

Research & Reviews  123 results

Alopecia totalis following hand-foot-and-mouth disease.
https://doi.org/10.1111/pde.14550
Pediatric Dermatology; Oska S, Bedford LM et. al.

Mar 2nd, 2021 - We present a case of a 13-month-old male patient with alopecia totalis that began two months after an episode of hand-foot-and-mouth disease. It is hypothesized that the viral infection triggered an autoimmune response, which lead to production of...

Therapeutic management in pediatric alopecia areata: a systematic review.
https://doi.org/10.1111/jdv.17187
Journal of the European Academy of Dermatology and Venere... Waśkiel-Burnat A, Kołodziejak M et. al.

Feb 25th, 2021 - Alopecia areata is the third-most-common cause of dermatology consultations in children but the treatment of pediatric alopecia areata remains challenging. A systematic review of the literature about the treatment of alopecia areata in children (≤...

Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evalua...
https://doi.org/10.1111/dth.14726
Dermatologic Therapy; Losol E, Şentürk N

Dec 30th, 2020 - Squaric acid dibutyl ester (SADBE) as topical immunotherapy is a good alternative in patients with refractory alopecia areata. In this study, we aimed to evaluate the effectiveness of SADBE treatment in alopecia areata (AA) and alopecia totalis/al...

Topical immunotherapy in combination with anthralin in the treatment of refractory alop...
https://doi.org/10.1111/jocd.13588
Journal of Cosmetic Dermatology REFERENCES; Kagami S, Kishi Y et. al.

Jul 5th, 2020 - Treatment is often challenging in patients with alopecia areata. We often try topical immunotherapy to treat alopecia areata in Japan. Anthralin is sometimes used in other countries. The aim of this study was to examine effectiveness of combinatio...

Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants ...
https://doi.org/10.1515/jpem-2019-0466
Journal of Pediatric Endocrinology & Metabolism : JPEM; Abalı S, Tamura M et. al.

Feb 12th, 2020 - Background Hereditary vitamin D-resistant rickets (HVDRR) is caused by vitamin D receptor (VDR) defects. Patients with HVDRR do not respond to standard doses of calcitriol and oral calcium (Ca) treatment and need to be treated with intravenous Ca ...

see more →

Clinicaltrials.gov  135 results

Alopecia totalis following hand-foot-and-mouth disease.
https://doi.org/10.1111/pde.14550
Pediatric Dermatology; Oska S, Bedford LM et. al.

Mar 2nd, 2021 - We present a case of a 13-month-old male patient with alopecia totalis that began two months after an episode of hand-foot-and-mouth disease. It is hypothesized that the viral infection triggered an autoimmune response, which lead to production of...

Therapeutic management in pediatric alopecia areata: a systematic review.
https://doi.org/10.1111/jdv.17187
Journal of the European Academy of Dermatology and Venere... Waśkiel-Burnat A, Kołodziejak M et. al.

Feb 25th, 2021 - Alopecia areata is the third-most-common cause of dermatology consultations in children but the treatment of pediatric alopecia areata remains challenging. A systematic review of the literature about the treatment of alopecia areata in children (≤...

Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evalua...
https://doi.org/10.1111/dth.14726
Dermatologic Therapy; Losol E, Şentürk N

Dec 30th, 2020 - Squaric acid dibutyl ester (SADBE) as topical immunotherapy is a good alternative in patients with refractory alopecia areata. In this study, we aimed to evaluate the effectiveness of SADBE treatment in alopecia areata (AA) and alopecia totalis/al...

Topical immunotherapy in combination with anthralin in the treatment of refractory alop...
https://doi.org/10.1111/jocd.13588
Journal of Cosmetic Dermatology REFERENCES; Kagami S, Kishi Y et. al.

Jul 5th, 2020 - Treatment is often challenging in patients with alopecia areata. We often try topical immunotherapy to treat alopecia areata in Japan. Anthralin is sometimes used in other countries. The aim of this study was to examine effectiveness of combinatio...

Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants ...
https://doi.org/10.1515/jpem-2019-0466
Journal of Pediatric Endocrinology & Metabolism : JPEM; Abalı S, Tamura M et. al.

Feb 12th, 2020 - Background Hereditary vitamin D-resistant rickets (HVDRR) is caused by vitamin D receptor (VDR) defects. Patients with HVDRR do not respond to standard doses of calcitriol and oral calcium (Ca) treatment and need to be treated with intravenous Ca ...

see more →

News  15 results

The Case of the Disappearing Eyebrows
https://www.mdedge.com/clinicianreviews/article/195335/dermatology/case-disappearing-eyebrows/page/0/1?channel=203

Feb 28th, 2019 - DISCUSSION This case illustrates several variants of an extremely common condition: alopecia areata (AA), literally translated as “hair loss confined to a particular localized area or areas. ” Although AA is more common in adults, it often affects.

Eczema Drug Dupilumab Spurs Hair Regrowth in Alopecia Totalis
https://www.medscape.com/viewarticle/903234

Oct 9th, 2018 - In addition to effectively treating a resistant case of atopic dermatitis, the eczema drug dupilumab (Dupixent, Regeneron Pharmaceutics) triggered hair growth in a young patient with longstanding alopecia totalis, investigators report. The dual ef...

JAK Inhibitors Promising for Alopecia Areata
https://www.staging.medscape.com/viewarticle/902077

Sep 16th, 2018 - PARIS — Two investigational oral Janus kinase (JAK) inhibitors are safe and effective for patients with moderate to severe hair loss, according to 24-week interim findings from a randomized, double-blind, placebo-controlled, multicenter phase 2 tr...

JAK Inhibitors Promising for Alopecia Areata
https://www.medscape.com/viewarticle/902077

Sep 16th, 2018 - PARIS — Two investigational oral Janus kinase (JAK) inhibitors are safe and effective for patients with moderate to severe hair loss, according to 24-week interim findings from a randomized, double-blind, placebo-controlled, multicenter phase 2 tr...

JAK inhibitors look good for severe alopecia areata treatment
https://www.mdedge.com/familymedicine/article/157463/dermatology/jak-inhibitors-look-good-severe-alopecia-areata-treatment
Pediatric News; Catherine Cooper Nellist

Jan 31st, 2018 - Janus kinase inhibitors look promising in the treatment of severe alopecia areata, particularly in adolescents, said Lucy Yichu Liu, MD, and Brett Andrew King, MD, of Yale University, New Haven, Conn. Standard medical therapies for alopecia areata.

see more →